期刊文献+

RP-HPLC法测定巴洛沙星的有关物质和降解产物 被引量:2

Determination of related substances and degradation products in balofloxacin by RP-HPLC
下载PDF
导出
摘要 目的:用HPLC法测定巴洛沙星中有关物质和降解产物。方法:色谱柱为Prodigy 5μODS3100A(150×4.60mm 5 micron),乙腈-0.05mol.L-1枸橼酸溶液(25∶75)为流动相,流速为1.0mL.min-1,检测波长为294.0nm。结果:巴洛沙星与各杂质均能有效的分离。结论:该方法结果准确,操作简单,灵敏度高,专属性强,适用于巴洛沙星的有关物质测定。 Objective: To establish an HPLC method for The determination of related substances and degradation products in balofloxacin. Method:HPLC with Prodigy 5u ODS3 100A (150 × 4.60mm 5 micron)as column, acetonitrile and 0. 05mol · L^-1 citric acid (25:75 ) as mobile phase, flow rate : 1.0mL · min^ - 1, UV detector at 294. Onm. Result: Balofloxacin and all of the related substances can be separated efficiently. Conclusion: The method is accurate, simple, specific and exclusive,it could be used for determination of related substances in balofloxaein.
出处 《化学工程师》 CAS 2008年第12期46-47,53,共3页 Chemical Engineer
关键词 巴洛沙星 高效液相色谱法 有关物质 降解产物 balofloxacin HPLC prelated substances degradation products
  • 相关文献

参考文献7

  • 1Kojima K, ho T, Munemura K, Kondo A, Matsumoto M, Nagano H. In Vitro antibacterial activity of balofloxacin [J]. Jpn J Chemother, 1995,43 ( $5 ) :60 - 76.
  • 2日本化学療法學会雑誌,1995,43(5):94-99.
  • 3Kojima K, ho T, Munemura K, Kondo A, Matsumoto M, Nagano H. In Vivo antibacterial activity of balofloxaein [ J ]. Jpn J Chemother, 1995,43 ( S5 ) :77 - 83.
  • 4刘明亮,刘秉全,孙兰英,郭慧元.巴洛沙星的合成[J].中国医药工业杂志,2004,35(7):385-388. 被引量:18
  • 5俞红,戴真南,缪玉山,石涛.用RP-HPLC法测定巴洛沙星中间体含量的方法学研究[J].现代医学,2004,32(2):85-87. 被引量:3
  • 6.ChP(中国药典).Vol Ⅱ(二部)[M].,2000.Appendix(附录)64.
  • 7ChP(中国药典).2005,Vol Ⅱ(二部):42

二级参考文献14

  • 1[2]Nakane T, Nakajima C, Mitsuhashi S. In vitro antibacterial activity of balofloxacin [J]. Nippon Kagaku Ryoho Gakkai Zasshi, 1995, 43 (S-5): 1-9.
  • 2[3]Marutani K, Matsumoto M, Otable Y, et al. Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with longwavelength UV light [J]. Antimicrob Agents Chemother, 1993,37 (10): 2217-2223.
  • 3[4]Shimizu H, Fujimura Y, Miura Y. Process for producing quinolonecarboxylic acid derivative [P]. WO: 9322308, 1993-11-11. (CA 1994, 120: 163997r)
  • 4[5]Masuzawa K, Suzue S, Hirai K, et al. Preparaton of 8-alkoxyquinolonecarboxylic acids as antibacterials with selective toxicity [P]. EP: 230295, 1987-07-29. (CA 1988, 108:75230g)
  • 5[6]Ataka K, Oku M, Kono M, et al. Preparaton of 7-amino-4-quinolonecarboxylic acids [P]. JP: 06157464, 1994-06-03. (CA 1994, 121: 230674u)
  • 6[7]Iwata M, Kimura T, Fujiwara Y, et al. Preparation of alkoxyfluoroquinolonecarboxylic acid derivatives as medical bactericides[P]. EP: 241206, 1987-10-14. (CA 1989, 110:135095v)
  • 7[8]Takagi N, Fubasami H, Matsukubo H. (6,7-Substituted-8-alkoxy- 1-cyclopropyl- 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid O3,O4) bis (acyloxy-O) borates and the salts thereof, and methods for their manufacture [P]. EP: 464823,1992-01-08. (CA 1992, 116: 152003e)
  • 8[9]Spaith E, Lintner J. Uber die bildung yon lactamen aus lactonen [J]. Bericht, 1936, 69: 2727-2731.
  • 9[10]Iselin BM, Hoffmann K. Uber alkylenimin-derivate. Synthese einiger 3-aryl-3-oxy-piperidine [J]. Helv Chim Acta, 1954, 37:178-184.
  • 10[11]Bender PE, Loev B. Pharmaceutical compositions and methods of inhibiting gastric acid secretion [P]. US: 3980788,1976-09-14. (CA 1976, 85: 182415z)

共引文献66

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部